Cargando…
Small- and Large-Fiber Neuropathy After 40 Years of Type 1 Diabetes: Associations with glycemic control and advanced protein glycation: the Oslo Study
OBJECTIVE: To study large- and small-nerve fiber function in type 1 diabetes of long duration and associations with HbA(1c) and the advanced glycation end products (AGEs) N-ε-(carboxymethyl)lysine (CML) and methylglyoxal-derived hydroimidazolone. RESEARCH DESIGN AND METHODS: In a long-term follow-up...
Autores principales: | Sveen, Kari Anne, Karimé, Bassam, Jørum, Ellen, Mellgren, Svein Ivar, Fagerland, Morten Wang, Monnier, Vincent M., Dahl-Jørgensen, Knut, Hanssen, Kristian F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816884/ https://www.ncbi.nlm.nih.gov/pubmed/24026557 http://dx.doi.org/10.2337/dc13-0788 |
Ejemplares similares
-
Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function
por: Brunvand, Leif, et al.
Publicado: (2017) -
The Oslo Ischaemia Study: cohort profile
por: Falk, Ragnhild Sørum, et al.
Publicado: (2021) -
Creatine kinase is associated with glycated haemoglobin in a nondiabetic population. The Tromsø study
por: Bekkelund, Svein Ivar
Publicado: (2023) -
Can vitamin D(3) supplementation prevent bone loss in persons with MS? A placebo-controlled trial
por: Steffensen, Linn H., et al.
Publicado: (2011) -
Pre-hospital treatment of acute poisonings in Oslo
por: Heyerdahl, Fridtjof, et al.
Publicado: (2008)